Morten Herholdt
Stock Analyst at HSBC
(1.55)
# 3,098
Out of 4,771 analysts
17
Total ratings
41.67%
Success rate
-5.01%
Average return
Main Sectors:
Stocks Rated by Morten Herholdt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LH Labcorp Holdings | Upgrades: Buy | n/a | $239.68 | - | 2 | Oct 30, 2024 | |
| ZTS Zoetis | Maintains: Buy | $230 → $225 | $164.43 | +36.84% | 2 | May 8, 2024 | |
| BIIB Biogen | Maintains: Buy | $339 → $342 | $143.09 | +139.01% | 2 | May 3, 2024 | |
| GILD Gilead Sciences | Upgrades: Hold | $69 | $110.23 | -37.40% | 2 | Apr 24, 2024 | |
| JNJ Johnson & Johnson | Upgrades: Buy | $169 → $170 | $164.25 | +3.50% | 2 | Apr 18, 2024 | |
| BLUE bluebird bio | Maintains: Reduce | $46 → $20 | $3.94 | +417.77% | 2 | Mar 5, 2024 | |
| UNH UnitedHealth Group | Initiates: Hold | $540 | $503.80 | +7.19% | 1 | Sep 6, 2023 | |
| LIVN LivaNova | Initiates: Hold | $52 | $40.41 | +28.68% | 1 | Sep 6, 2023 | |
| IQV IQVIA Holdings | Initiates: Buy | $260 | $188.54 | +37.90% | 1 | Sep 6, 2023 | |
| AMGN Amgen | Initiates: Buy | $320 | $318.65 | +0.42% | 1 | Sep 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.19 | +874.79% | 1 | Sep 6, 2023 |
Labcorp Holdings
Oct 30, 2024
Upgrades: Buy
Price Target: n/a
Current: $239.68
Upside: -
Zoetis
May 8, 2024
Maintains: Buy
Price Target: $230 → $225
Current: $164.43
Upside: +36.84%
Biogen
May 3, 2024
Maintains: Buy
Price Target: $339 → $342
Current: $143.09
Upside: +139.01%
Gilead Sciences
Apr 24, 2024
Upgrades: Hold
Price Target: $69
Current: $110.23
Upside: -37.40%
Johnson & Johnson
Apr 18, 2024
Upgrades: Buy
Price Target: $169 → $170
Current: $164.25
Upside: +3.50%
bluebird bio
Mar 5, 2024
Maintains: Reduce
Price Target: $46 → $20
Current: $3.94
Upside: +417.77%
UnitedHealth Group
Sep 6, 2023
Initiates: Hold
Price Target: $540
Current: $503.80
Upside: +7.19%
LivaNova
Sep 6, 2023
Initiates: Hold
Price Target: $52
Current: $40.41
Upside: +28.68%
IQVIA Holdings
Sep 6, 2023
Initiates: Buy
Price Target: $260
Current: $188.54
Upside: +37.90%
Amgen
Sep 6, 2023
Initiates: Buy
Price Target: $320
Current: $318.65
Upside: +0.42%
Sep 6, 2023
Initiates: Buy
Price Target: $12
Current: $1.19
Upside: +874.79%